Products for Research Use Only
RegisterLogin

Plutavimab

CAT: 0804-HY-P99104-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99104-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Plutavimab a human IgG1-κ anti-SARS-CoV-2 antibody, targeting to Spike (S) glycoprotein receptor binding domain (RBD) [1][2].
CAS Number
2529854-88-2
Product Name Alternative
COVI-AMG; STI-2020
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/plutavimab.html
Purity
98.619
Solubility
10 mM in DMSO|H2O
Smiles
[Plutavimab]
Molecular Weight
(143.981 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Williams, et al. Engineering of antibodies to coronavirus SARS-CoV-2 for diagnosis and treatment. World Intellectual Property Organization, WO2023070051 A1. 2023-04-27.|[2]Plutavimab. IMGT/mAb-DB.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T80581-01Plutavimab
GTR18398530-01Plutavimab Antibody
MBS1564043-01Research Grade Plutavimab
E55B0888Plutavimab (Reference antibody)
GTR18780293-01(Plutavimab) Biosimilar Reference Antibody
ICH5779-50mgPlutavimab Biosimilar - Research Grade
GTR18697216-01Plutavimab Human Monoclonal Antibody
A135620Plutavimab Biosimilar (Monoclonal, IgG1, kappa)
RA0660-01Plutavimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)
PX-TA1878-01Plutavimab Biosimilar - Anti-SARS-CoV-2 Spike RBD mAb - Research Grade

Popular Products